Dxome Co., Ltd. is a molecular diagnostics company specializing in next-generation sequencing (NGS)–based solutions with a strong focus on liquid biopsy. By analyzing circulating tumor DNA (ctDNA) and hereditary mutations from a simple blood sample, Dxome enables early cancer detection, treatment se...